Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk.

Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk.

Cardiovascular disease (CVD) is one of the greatest disease burdens and takes the lives of many each year. There are many risk factors both modifiable and non-modifiable which contribute to the onset and progression of the disease. Trimethylamine N-oxide (TMAO) in recent years has been found to have...

Full description

Bibliographic Details
Main Authors: Swanepoel, Ione, Roberts, April, Brauns, Chelsea, Chaliha, Devahuti, Papa, Veronica, Palmer, Raymond D, Vaccarezza, Mauro
Format: Journal Article
Language:English
Published: 2021
Subjects:
adult cardiology
biophysics
coronary heart disease
microbiology
pathology
vascular medicine
Online Access:http://hdl.handle.net/20.500.11937/83145

Internet

http://hdl.handle.net/20.500.11937/83145

Similar Items